Adhesion receptors of vascular smooth muscle cells and their functions

Cardiovascular Research

Volumn 52, Issue 3, 2001, Pages 372-386

  Moiseeva, Elena P ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Extracellular matrix; Receptors; Smooth muscle

Indexed keywords

CELL ADHESION MOLECULE; DYSTROGLYCAN; INTEGRIN; NERVE CELL ADHESION MOLECULE; SCLEROPROTEIN; SYNDECAN;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; HUMAN; MUSCLE FIBER CONTRACTION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STRESS; VASCULAR SMOOTH MUSCLE;

CADHERINS; CARDIOVASCULAR DISEASES; CELL ADHESION; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; EXTRACELLULAR MATRIX; HUMANS; INTEGRINS; LAMININ; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; SYNDECANS;

EID: 0035216201     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00399-6     Document Type: Review

References (203)

1. Smooth muscle migration in atherosclerosis and restenosis
2. The intima - A new soil
3. A comparison of aorta and vena cava medial message expression by cDNA array analysis identities a set of 68 consistently differentially expressed genes, all in aortic media
4. Regulation of differentiation of vascular smooth-muscle cells
5. Regulation of differentiated properties and proliferation of arterial smooth-muscle cells
6. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis
7. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin
8. Extracellular matrix of the human aortic media: An ultrastructural histochemical and immunohistochemical study of the adult aortic media
9. Composition in situ and in vitro of vascular smooth-muscle laminin in the rat
10. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth-muscle cells
11. Fibronectin and the basement-membrane components laminin and collagen type-IV influence the phenotypic properties of subcultured rat aortic smooth-muscle cells differently
12. Vascular smooth-muscle cells grown on matrigel - A model of the contractile phenotype with decreased activation of mitogen-activated protein-kinase
13. Effect of extracellular-matrix proteins on vascular smooth- muscle cell phenotype
14. Role of tyrosine kinases in extracellular matrix-mediated modulation of arterial smooth muscle cell phenotype
15. Focal adhesions - The cytoskeletal connection
16. Integrin-mediated adhesion and signaling in tumorigenesis
17. Recent advances in cell adhesion molecules and extracellular matrix proteins: Potential clinical implications
18. Integrin signaling and cell growth control
19. Transduction - Integrin signaling
20. Human smooth-muscle VLA-1 integrin - Purification, substrate- specificity, localization in aorta, and expression during development
21. An α-1/β-1-like integrin receptor on rat aortic smooth-muscle cells mediates adhesion to laminin and collagen type-I and type-IV
22. β-1 and β-3 integrins have different roles in the adhesion and migration of vascular smooth-muscle cells on extracellular-matrix
23. Cell-adhesion receptors for native and denatured type-I collagens and fibronectin in rabbit arterial smooth-muscle cells in culture
24. Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury
25. Laminin variants and integrin laminin receptors in developing and adult human smooth-muscle
26. Dynamic expression of α-1-β-1 and α-2-β-1 integrin receptors by human vascular smooth-muscle cells - α-2-β-1 integrin is required for chemotaxis across type-I collagen-coated membranes
27. Distribution and quantification of α(1)-integrin subunit in rat organs
28. Changes in endothelial cell and smooth muscle cell integrin expression during closure of the ductus arteriosus: An immunohistochemical comparison of the fetal, preterm newborn, and full-term newborn rhesus monkey ductus
29. The expression of β1 integrins in human coronary artery
30. The α1β1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization
31. Integrin-mediated collagen matrix reorganization by cultured human vascular smooth-muscle cells
32. Ligand occupancy of the αVβ3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor I
33. Role of β1 and β3 integrins in human smooth muscle cell adhesion to and contraction of fibrin clots in vitro
34. Expression of phenotype- and proliferation-related genes in rat aortic smooth muscle cells in primary culture
35. The A and B variants of the α3 integrin subunit: Tissue distribution and functional characterization
36. Osteopontin is a ligand for the α(4)β(1) integrin
37. Expanding roles for α-4 integrin and its ligands in development
38. The integrin very late antigen-4 is expressed in human smooth muscle cell - Involvement of α(4) and vascular cell adhesion molecule-1 during smooth muscle cell differentiation
39. A regulated interaction between α5β1 integrin and osteopontin
40. Human carotid artery smooth muscle cells rarely express αvβ3 integrin at sites of recent plaque rupture
41. α5β1 Integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury
42. Recombinant laminin-8 (α(4)β(1) γ(1)) - Production, purification, and interactions with integrins
43. Ductus-arteriosus smooth-muscle cell-migration on collagen - Dependence on laminin and its receptors
44. The α(6) and β(4) integrin subunits are expressed by smooth-muscle cells of human small vessels - A new localization in mesenchymal cells
45. The role of extracellular and cytoplasmic splice domains of α7 integrin in cell adhesion and migration on laminins
46. α7 Integrin mediates cell adhesion and migration on specific laminin isoforms
47. Functional expression of the α7 integrin receptor in differentiated smooth muscle cells
48. The human integrin α-8-β-1 functions as a receptor for tenascin, fibronectin and vitronectin
49. Identification of osteopontin as a novel ligand for the integrin α8β1 and potential roles for this integrin-ligand interaction in kidney morphogenesis
50. Sequence and tissue distribution of the human integrin α-8-subunit - A β(1)-associated α-subunit expressed in smooth-muscle cells
51. The integrin α-9-β-1 mediates cell attachment to a non-RGD site in the 3rd fibronectin type-III repeat of tenascin
52. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by α(9)β(1) integrin
53. The integrin α(9)β(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin
54. The integrin α9β1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1
55. Sequence and tissue distribution of the integrin-α-9 subunit, a novel partner of β-1 that is widely distributed in epithelia and muscle
56. Integrins mediate adhesion to agrin and modulate agrin signaling
57. Adhesive and migratory effects of osteopontin are mediated via distinct cell-surface integrins - Role of α(v)β(3) in smooth-muscle cell-migration to osteopontin in vitro
58. Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): A possible mechanism for influencing restenosis
59. α(v)β(3) Integrin expression in normal and atherosclerotic artery
60. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque
61. Selective αvβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: Evidence for the functional importance of integrin αvβ3 and osteopontin expression during neointima formation
62. αvβ3, αvβ5 and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation
63. β(3) Integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells
64. Mechanical strain of rat vascular smooth-muscle cells is sensed by specific extracellular matrix-integrin interactions
65. Regulation and function of an activation-dependent epitope of the β1 integrins in vascular cells after balloon injury in baboon arteries and in vitro
66. Regulation of β(1)-integrin function in cultured human vascular smooth muscle cells
67. The muscle-specific laminin receptor α7β1 integrin negatively regulates α5β1 fibronectin receptor function
68. Smooth muscle cell phenotype-dependent transcriptional regulation of the α 1 integrin gene
69. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis - A report from the committee on vascular-lesions of the council on arteriosclerosis
70. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas
71. Light microscopic immunolocation of thrombospondin in human tissues
72. Osteopontin is synthesized by macrophage, smooth-muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques
73. Laminin polymerization induces a receptor-cytoskeleton network
74. Identification of integrins involved in cell-adhesion to native and denatured type-I collagens and the phenotypic transition of rabbit arterial smooth-muscle cells
75. Inhibition of vascular smooth muscle cell growth by inhibition of fibronectin matrix assembly
76. β3 Integrin activation improves αvβ3-mediated retraction of fibrin matrices
77. Role of α5β1 and αvβ3 integrins on smooth muscle cell spreading and migration in fibrin gels
78. Osteopontin-stimulated vascular smooth-muscle cell-migration is mediated by β(3) integrin
79. The role of integrins in saphenous vein vascular smooth muscle cell migration
80. Fibroblast growth factor-2 potentiates vascular smooth muscle cell migration to platelet-derived growth factor - Upregulation of α(2)β(1) integrin and disassembly of actin filaments
81. Stimulation of migration of human aortic smooth-muscle cells by vitronectin - Implications for atherosclerosis
82. Potential roles of osteopontin and α(v)β(3) integrin in the development of coronary artery restenosis after angioplasty
83. Inhibition of neointimal hyperplasia by blocking α(v)β(3), integrin with a small peptide antagonist GpenGRGDSPCA
84. Inhibition of vascular smooth muscle cell migration by peptide and antibody antagonists of the α(v)β(3) integrin complex is reversed by activated calcium/calmodulin-dependent protein kinase II
85. Synthetic αVβ3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication
86. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation
87. β(3)-Integrins rather than β(1)-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration
88. Regulation of integrin function by the urokinase receptor
89. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
90. Identification of a urokinase receptor-integrin interaction site - Promiscuous regulator of integrin function
91. The thrombospondin receptor CD47 (IAP) modulates and associates with α2β1 integrin in vascular smooth muscle cells
92. Integrin-associated protein stimulates α2β1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases
93. Tetraspanin CD9 is associated with very late-acting integrins in human vascular smooth muscle cells and modulates collagen matrix reorganization
94. 2+]i induced by RGD-containing peptide
95. Modulation of calcium current in arteriolar smooth muscle by α(v)β(3) and α(5)β(1) integrin
96. Vascular smooth muscle α(v)β(3) integrin mediates arteriolar vasodilation in response to RGD peptides
97. Vitronectin regulates smooth muscle contractility via α(v) and β(1) integrin(s)
98. Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells
99. Activation of integrin receptors is required for growth factor- induced smooth muscle cell dysfunction
100. αvβ3 Integrin associates with activated insulin and PDGF β receptors and potentiates the biological activity of PDGF
101. The synergistic activity of α(v)β(3) integrin and PDGF receptor increases cell migration
102. Reduced intimal thickening following αvβ3 blockade is associated with smooth muscle cell apoptosis
103. Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (α(v)β(3)), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits
104. The role of cytoskeletal proteins in cardiomyopathies
105. Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy
106. Molecular and genetic characterization of sarcospan: Insights into sarcoglycan-sarcospan interactions
107. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations
108. Dystrophin protects the sarcolemma from stresses developed during muscle contraction
109. Mechanical function of dystrophin in muscle cells
110. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector
111. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex
112. The crystal structure of a laminin G-like module reveals the molecular basis of α-dystroglycan binding to laminins, perlecan, and agrin
113. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction
114. Developmental regulation of perlecan gene expression in aortic smooth muscle cells
115. Distinct rat aortic smooth muscle cells differ in versican/PG-M expression
116. A role for dystroglycan in basement membrane assembly
117. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice
118. Absence of integrin α7 causes a novel form of muscular dystrophy
119. Dystroglycan versatility
120. Disruption of the β-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E
121. ε-Sarcoglycan replaces α-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex
122. Biochemical characterization of the epithelial dystroglycan complex
123. Dystrophin (Xp21), a new phenotype marker of cultured rat aortic myocytes
124. Parallel expression level of dystrophin and contractile performances of rat aortic smooth-muscle
125. Different utrophin and dystrophin properties related to their vascular smooth muscle distributions
126. The subcellular-distribution of dystrophin in mouse skeletal, cardiac, and smooth-muscle
127. Complementary distributions of vinculin and dystrophin define 2 distinct sarcolemma domains in smooth muscle
128. Structure-function relationships in smooth muscle - The missing links
129. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of 19 monoclonal antibodies - Presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain-cell lines
130. Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: Recruitment to focal adhesions is dependent upon extracellular ligands
131. Association of aciculin with dystrophin and utrophin
132. A novel dystrophin utrophin-associated protein is an enzymatically inactive member of the phosphoglucomutase superfamily
133. A novel phosphoglucomutase-related protein is concentrated in adherens junctions of muscle and nonmuscle cells
134. Mechanical properties of smooth muscle portal vein in normal and dystrophin-deficient (mdx) mice
135. Blood loss in Duchenne muscular dystrophy: Vascular smooth muscle dysfunction?
136. Cardiomyopathy in Duchenne, Becker, and sarcoglycanopathies: A role for coronary dysfunction?
137. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
138. Identification of the syrian hamster cardiomyopathy gene
139. Delineation of genomic deletion in cardiomyopathic hamster
140. Microvascular spasm in the cardiomyopathic syrian hamster - A preventable cause of focal myocardial necrosis
141. Syndecans: Multifunctional cell-surface co-receptors
142. Heparan sulfate proteoglycans on the cell surface: Versatile coordinators of cellular functions
143. Identification of an adhesion site within the syndecan-4 extracellular protein domain
144. Syndecans, signaling, and cell adhesion
145. Molecular interactions of the syndecan core proteins
146. Syndecan-4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component
147. Control of morphology, cytoskeleton and migration by syndecan-4
148. Syndecan-4 core protein is sufficient for the assembly of focal adhesions and actin stress fibers
149. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers
150. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to β1 integrin-dependent cell spreading
151. Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts
152. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin α5β1: Structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin
153. Control of extracellular matrix assembly by syndecan-2 proteoglycan
154. Syndecan-regulated receptor signaling
155. The syndecan family of proteoglycans - Novel receptors mediating internalization of atherogenic lipoproteins in vitro
156. Syndecan-4 is a primary response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells
157. Smooth-muscle cell expression of extracellular-matrix genes after arterial injury
158. Regulated expression of syndecan in vascular smooth-muscle cells and cloning of rat syndecan core protein cDNA
159. Differential expression of transmembrane proteoglycans in vascular smooth-muscle cells
160. Thrombin stimulates syndecan-1 promotor activity and expression of a form of syndecan-1 that binds antithrombin III in vascular smooth muscle cells
161. Association of intercellular-adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and α-actinin
162. Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2) - Regulation by phosphatidylinositol-4,5-bisphosphate
163. Regulation of integrin function and cellular adhesion
164. The leukocyte integrin α(D)β(2) binds VCAM-1: Evidence for a binding interface between I domain and VCAM-1
165. Integrins as dynamic regulators of vascular function
166. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway
167. Structural recognition of a novel fibrinogen γ-chain sequence (117-133) by intercellular-adhesion molecule-1 mediates leukocyte-endothelium interaction
168. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular-adhesion molecule 1-fibrinogen recognition
169. Cellular adhesion molecules on vascular smooth muscle cells
170. Inducible expression of vascular cell-adhesion molecule-1 by vascular smooth-muscle cells in vitro and within rabbit atheroma
171. Vascular cell-adhesion molecule-1 is expressed in human coronary atherosclerotic plaques - Implications for the mode of progression of advanced coronary atherosclerosis
172. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content
173. Activation of the NF-κB and I κB system in smooth muscle cells after rat arterial injury - Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1
174. Expression of intercellular adhesion molecules in human saphenous veins: Effects of inflammatory cytokines and neointima formation in culture
175. ICAM-1 expression by vascular smooth muscle cells is phenotype-dependent
176. Regulation of vascular cell-adhesion molecule-1 and intercellular-adhesion molecule-1 in human vascular smooth muscle cells
177. TGF-β and endothelial cells inhibit VCAM-1 expression on human vascular smooth-muscle cells
178. Interleukin-1-β induces expression of adhesion molecules in human vascular smooth-muscle cells and enhances adhesion of leukocytes to smooth-muscle cells
179. TNF-α and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells
180. Enhancement of monocyte procoagulant activity by adhesion on vascular smooth muscle cells and intercellular adhesion molecule-1-transfected Chinese hamster ovary cells
181. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-κB-independent mechanism
182. A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1
183. Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival
184. Src homology domain 2-containing tyrosine phosphatase 2 associates with intercellular adhesion molecule 1 to regulate cell survival
185. 2+-dependent cell cell-adhesion molecule expressed in the retina
186. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
187. Cell adhesion molecules, signal transduction and cell growth
188. A potential role for N-cadherin in mediating endothelial cell-smooth muscle-cell interactions in the rat vasculature
189. A potential role of R-cadherin in striated muscle formation
190. Identification of an atypical lipoprotein-binding protein from human aortic smooth muscle as T-cadherin
191. Identification of 130-kDa cell surface LDL-binding protein from smooth muscle cells as a partially processed T-cadherin precursor
192. Differential regulation of cadherins in injured rat carotids
193. Phenotype-dependent expression of cadherin 6B in vascular and visceral smooth muscle cells
194. Cadherin expression is altered during intimal thickening in human saphenous vein
195. Functional and expression characteristics of human T-cadherin: A differential marker?
196. Density- and proliferation status-dependent expression of T- cadherin, a novel lipoprotein-binding glycoprotein: A function in negative regulation of smooth muscle cell growth?
197. Characteristics of smooth muscle cell lipoprotein binding proteins (p105/p130) as T-cadherin and regulation by positive and negative growth regulators
198. The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions
199. p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry
200. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)
201. E-Cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway
202. Cross talk between adhesion molecules: Control of N-cadherin activity by intracellular signals elicited by β1 and β3 integrins in migrating neural crest cells
203. Loss of cell-surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyma-like cells